Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

130
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
130
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

252
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
252

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association Between Statin Initiation and Myasthenia Gravis Crisis.

Journal of clinical neurology (Seoul, Korea)·2026
Same author

GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.

Diabetes, obesity & metabolism·2026
Same author

Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study.

Blood cancer journal·2026
Same author

Systemic atopy and upper-airway disease define susceptibility to incident asthma after COVID-19 in Korea.

Nature communications·2026
Same author

Computational Insights Into Smart Bioelectronics in Digital Health Care (2020-2024): Topic Modeling Study.

JMIR medical informatics·2026
Same author

A Practical Approach to Assessing the Completeness of Electronic Health Records for Medical Research: Data Quality Study.

JMIR medical informatics·2026

相关实验视频

Updated: Sep 16, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

587

从生物医学BERT模型中嵌入的参数知识中预测药物副作用关系:使用自然语言处理方法进行方法学研究.

Woohyuk Jeon1, Minjae Park1, Doyeon An1

  • 1Department of Computer Engineering, College of IT Convergence, Gachon University, AI·Engineering Building, 317A, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Seongnam, 13120, Republic of Korea, 82 010-9012-9364, 82 031-750-5333.

JMIR medical informatics
|July 10, 2025
PubMed
概括

这项研究引入了一种使用生物医学BERT模型来预测未知的药物副作用关系的新方法,其性能优于传统模型. 该方法在管理药物不良反应方面表现出高准确性和实际适用性.

关键词:
预测ADR的预测贝尔特 (BERT) 公司来自变压器的双向编码器表示在NLP中,我们使用了NLP.药物不良反应 药物不良反应药物副作用关系关系 药物副作用关系自然语言处理自然语言处理.一个词嵌入的词嵌入.

更多相关视频

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

692
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

相关实验视频

Last Updated: Sep 16, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

587
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

692
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

科学领域:

  • 生物医学信息学 生物医学信息学
  • 自然语言处理自然语言处理.
  • 药物监督 药物监督 药物监督

背景情况:

  • 药物不良反应 (ADR) 对患者健康构成重大风险.
  • 传统的词嵌入模型,如Word2Vec与生物医学文本特异性作斗争.
  • 伯特模型显示出有希望的结果,但需要进一步的研究来预测未知的药物副作用关系.

研究的目的:

  • 用生物医学BERT模型的参数知识来预测新的药物副作用关系.
  • 为了提高预测,利用已知的关系的嵌入向量相似性来提高预测.
  • 识别潜在的药物副作用候选者,其因果机制未知.

主要方法:

  • 利用来自SIDER数据库的158,096种药物副作用对来创建一个相邻矩阵.
  • 计算了药物和副作用词嵌入矢量之间的共弦相似性.
  • 计算了8,235,435种药物副作用对的关系得分,并使用曲线下的面积 (AUC) 进行评估.

主要成果:

  • 在clagator/biobert_v1.1模型中,AUC达到0.915,超过了Word2Vec (AUC为0.848).
  • 在生物医学体上预训练的BERT模型表现优于香草BERT (AUC 0.857).
  • 外部验证与FDA不良事件报告系统数据显示高统计意义 (P<.001,OR=4.822).

结论:

  • 使用预训练的生物医学语言模型开发了一种用于预测药物副作用关系的新方法.
  • 基于BERT的模型优秀地预测药物副作用关系,这是由于上下文理解.
  • 该方法证明了预测和管理ADR的实际实用性.